Executive Summary
Japan CSF Management Market Outlook to 2023
Summary
GlobalData's new report, "Japan CSF Management Market Outlook to 2023", provides key market data on the Japan CSF Management market. The report provides value, in millions of US dollars, volume (in units) and and average prices (USD) within market segments-Hydrocephalus Shunts and Dura Substitutes.
The report also provides company shares and distribution shares data for each of these market segments, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the report.
Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.
Scope
Market size and company share data for CSF Management market segments-Hydrocephalus Shunts and Dura Substitutes.
Annualized market revenues (USD million) and volume (units) data for each of the market segments. Data is provided from 2009 to 2016 and forecast to 2023.
2016 company shares and distribution shares data for each of the market segments.
Global corporate-level profiles of key companies operating within the Japan CSF Management market.
Key players covered include Integra LifeSciences Holdings Corp, Medtronic plc, DePuy Synthes Inc and Others.
Reasons to buy
Develop business strategies by identifying the key market segments poised for strong growth in the future.
Develop market-entry and market expansion strategies.
Design competition strategies by identifying who-stands-where in the market.
Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
What are the key distribution channels and what's the most preferred mode of product distribution-Identify, understand and capitalize.
Read More
Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications
ankur [@] kenresearch.com
+91-9015378249
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 3
1.2 List of Figures 3
2 Introduction 4
2.1 What Is This Report About? 4
2.2 CSF Management Market Segmentation 4
2.3 Definitions of Markets Covered in the Report 5
3 CSF Management Market, Japan 6
3.1 CSF Management Market, Japan, Revenue ($m), 2009-2016 6
3.2 CSF Management Market, Japan, Revenue ($m), 2016-2023 8
3.3 CSF Management Market, Japan, Volume (Units), 2009-2016 10
3.4 CSF Management Market, Japan, Volume (Units), 2016-2023 12
3.5 CSF Management Market, Japan, Average Price ($), 2009-2023 14
3.6 CSF Management Market, Japan, Distribution Share by Revenue ($m), 2015-2016 15
3.7 CSF Management Market, Japan, Company Share by Revenue ($m), 2016 16
4 Overview of Key Companies in Japan, CSF Management Market 18
4.1 W. L. Gore & Associates Inc 18
4.1.1 Company Overview 18
4.2 Medtronic Plc 18
4.2.1 Company Overview 18
4.3 DePuy Synthes Inc 18
4.3.1 Company Overview 18
4.4 Integra LifeSciences Holdings Corp 18
4.4.1 Company Overview 18
5 CSF Management Market Pipeline Products 19
6 Appendix 20
6.1 Research Methodology 21
6.1.1 Coverage 21
6.1.2 Secondary Research 21
6.1.3 Primary Research 22
6.1.4 Company Share Analysis 22
6.1.5 Distribution Share Analysis 22
6.1.6 Benchmarking 23
6.2 GlobalData Consulting 23
6.3 Contact Us 24
6.4 Disclaimer 24
1.1 List of Tables
Table 1: CSF Management Market, Japan, Revenue ($m), USD Constant, Historic, 2009-2016 7
Table 2: CSF Management Market, Japan, Revenue ($m), USD Constant, Forecast, 2016-2023 9
Table 3: CSF Management Market, Japan, Volume (Units), Historic, 2009-2016 11
Table 4: CSF Management Market, Japan, Volume (Units), Forecast, 2016-2023 13
Table 5: CSF Management Market, Japan, Average Price ($), Historic, 2009-2016 14
Table 6: CSF Management Market, Japan, Average Price ($), Forecast, 2016-2023 14
Table 7: CSF Management Market, Japan, Distribution Share by Revenue ($m), USD Constant, 2015-2016 15
Table 8: CSF Management Market, Japan, Company Share by Revenue ($m), USD Constant, 2016 17
Table 9: CSF Management Market Pipeline Products 19
Single User License:
Report can be used by individual purchaser only
Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office
Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company
W. L. Gore & Associates Inc, Medtronic Plc, DePuy Synthes Inc, Integra LifeSciences Holdings Corp
Neurology Devices, CSF Management, Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices, Neurosurgical Products, Radiosurgery, Value (USD), Volume (units), Revenues, Historic Revenues, Forecast Revenues, Average Price, Company Share, Distribution Share by Revenue, Company Share by Revenue, Pipeline Products, News, Deals, Key Companies, Medtronic plc, St. Jude Medical LLC, Boston Scientific Corp, DePuy Synthes Inc, LivaNova PLC, Stryker Corporation, Natus Medical Incorporated, Terumo Corp, Elekta AB, Integra LifeSciences Holdings Corp, B. Braun Melsungen AG, Nihon Kohden Corp, Accuray Inc, KARL STORZ GmbH & Co KG, MIZUHO Co., Ltd., W. L. Gore & Associates Inc, Sophysa SA
|
Agriculture and Animal Care
Automotive, Transportation and Warehousing
Banking Financial Services and Insurance
Consumer Products and Retail
Defense and Security
Education and Recruitment
Energy and Utilities
Food, Beverage and Tobacco
Healthcare
Manufacturing and Construction
Media and Entertainment
Metal, Mining and Chemicals
Public Sector and Administration
Technology and Telecom
